Ditchcarbon
  • Contact
  1. Organizations
  2. Vifor Pharma Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated 2 months ago

Vifor Pharma Ltd. Sustainability Profile

Company website

Vifor Pharma Ltd., a leading global pharmaceutical company headquartered in Switzerland (CH), specialises in iron deficiency and nephrology. Founded in 2000, Vifor Pharma has established itself as a key player in the industry, focusing on innovative therapies that address critical health needs. The company operates extensively across Europe, North America, and Asia, delivering high-quality products that enhance patient outcomes. Vifor Pharma's core offerings include intravenous iron therapies and treatments for chronic kidney disease, distinguished by their efficacy and safety profiles. The company has achieved notable milestones, including strategic partnerships and a robust pipeline of products that cater to underserved patient populations. With a strong market position, Vifor Pharma continues to drive advancements in the pharmaceutical sector, committed to improving the lives of patients worldwide.

DitchCarbon Score

How does Vifor Pharma Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

49

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Vifor Pharma Ltd.'s score of 49 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

70%

Let us know if this data was useful to you

Vifor Pharma Ltd.'s reported carbon emissions

Inherited from Csl Behring AG

Vifor Pharma Ltd., headquartered in Switzerland (CH), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of CSL Limited, which influences its climate commitments and reporting practices. Vifor Pharma's climate initiatives and reduction targets are inherited from CSL Limited, which operates at a cascade level of 2. However, there are no documented reduction targets or specific climate pledges available for Vifor Pharma at this time. As part of the broader industry context, Vifor Pharma is expected to align with the sustainability and climate strategies of its parent company, CSL Limited, which may include participation in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). In summary, while Vifor Pharma Ltd. does not currently provide specific emissions data or reduction targets, it is positioned within a corporate structure that prioritises climate commitments through its parent company, CSL Limited.

How Carbon Intensive is Vifor Pharma Ltd.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Vifor Pharma Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Vifor Pharma Ltd.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Vifor Pharma Ltd. is in CH, which has a very low grid carbon intensity relative to other regions.

Vifor Pharma Ltd.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Vifor Pharma Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Vifor Pharma Ltd.'s Emissions with Industry Peers

Pharmacosmos

DK
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Sanofi-Aventis U.S. LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Fresenius Medical Care Holdings, Inc.

US
•
Health and social work services (85)
Updated about 1 month ago

American Regent, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251030.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy